Outpatient treatment of infective endocarditis

Clinical Microbiology and Infection

Volumn 4, Issue SUPPL. 3, 1998, Pages 3s47-3s55

  Francioli, Patrick B ^a   Stamboulian, Daniel ^b   Durack, D T ^c   Leport, C ^c   Wilson, W R ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Centro de Estudios Infectologicos   (Argentina)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; BETA LACTAM; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; LIDOCAINE; NETILMICIN; OXACILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; BACTERIAL ENDOCARDITIS; CATHETER INFECTION; CONGESTIVE HEART FAILURE; DRUG FEVER; DRUG TOXICITY; ECHOCARDIOGRAPHY; EMBOLISM; HOME CARE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MYCOTIC ANEURYSM; ORAL DRUG ADMINISTRATION; OUTPATIENT; PATIENT COMPLIANCE; PATIENT SELECTION; PHLEBITIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS BOVIS;

EID: 0031738965     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Gilbert DN, Dworkin RJ, Raber SR, Leggett JE. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med 1997; 337: 829-38.
2. Francioli PB. Ceftriaxone and outpatient treatment of infective endocarditis. Infect Dis Clin North Am 1993: 97-115.
3. Patton JP. Economic considerations: In Donald K, ed. Infective endocarditis, 2nd edn. New York: Raven Press, 1992: 413-22.
4. Blackett K. Endocarditis in Cameroon. J R Coll Phys 1989; 23: 260-3.
5. Francioli P, Etienne J, Hoigné R, Thys JP. Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone for 4 weeks: efficacy and out-patient treatment feasibility. JAMA 1992; 267: 264-7.
6. Francioli PB, Glauser MP. Synergistic activity of ceftriaxone combined with netilmicin administered in one daily dose in the treatment of experimental streptococcal endocarditis. Antimicrob Agents Chemother 1993; 37: 207-12.
7. Blatter M, Fluckiger U, Entenza J, Glauser MP, Francioh P. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Annmicrob Agents Chemother 1993; 37 1971-7.
8. Francioli P, Ruch W, Stamboulian D, the International Infective Study Group. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995; 21: 1406-10.
9. Dinubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994, 121: 873-6
10. Dworkin RJ, Sande MA, Lee BL, Chambers HE Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989; 2: 1071-3.
11. Heldman AW, Hartert TV, Ray SC, et al. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996; 101: 68-76
12. Stamboulian D, Bonvehi P, Arevalo C, et al. Antibiotic management of outpatients with endocarditis due to penicillinsusceptible streptococci. Rev Infect Dis 1991; 13(suppl 2): S160-3
13. Hindes R, Winkler C, Kane P, Kunkel M. Outpatient intravenous antibiotic therapy in medicare patients: cost-savings analysis. Infect Dis Clin Pract 1995; 4: 211-17.
14. Dunayuga E, Brown RB. Outpatient parenteral antibiotic therapy for infective endocarditis. Infect Dis Clin Pract 1995; 4: 468-71
15. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991; 114: 635-40.
16. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and trans-oesophageal approach. J Am Coll Cardiol 1989; 14: 631-8.
17. Erbel R, Rohmann S, Drexler M Improved diagnostic value of echocardiography in patients with infective endocarditis by transesophageal approach. a prospective study. Eur Heart J 1988; 1: 43-53.
18. Lutas EM, Roberts RB, Devreux RB, Prieto LM. Relation between the presence of echocardiographic vegetations and the complication rate in infective endocarditis. Am Heart J 1986; 112: 107
19. Sanfilippo AJ, Picard MH, Newell JB, et al. Echocardiographic assessment of patients with infectious endocarditis. prediction of risk for complications. J Am Coll Cardiol 1991; 18: 1191-9.
20. Francioh PB. Complications of infective endocarditis. In Scheid WM, Whidey RJ, Durack DT, eds. Infections of the central nervous system. Philadelphia: Lippincort-Raven, 1997: 523-53.
21. Stamboulian D. Outpatient treatment of endocarditis in a clinicbased program in Argentina. Clin Microbiol Infect Dis 1995; 14: 648-54
22. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995; 274: 1706-13.
23. Sexton D, Tenenbaum MJ, Wilson W, et al. Ceftriaxone once daily for four weeks vs ceftriaxone plus gentamicin for two weeks for the treatment of penicillin-susceptible streptococcal endocarditis [abstract]. Infectious Diseases Society of America 1996.
24. Venditti M, Gelfusa V, Serra P, Brandimarte C, Micozzi A, Marrino P. 4-Week treatment of streptococcal native valve endocarditis with high-dose teicoplanin. Antimicrob Agents Chemother 1992; 36: 723-6.
25. Chambers H, Kennedy S, Fournier M, et al. Ceftriaxone vs. procaine penicillin alone and with gentamicin in viridans streptococcal aortic valve endocarditis in rabbits [abstract]. Interscience Conference on Antimicrobial Agents and Chemotherapy 1990; 701.
26. Wilson WR, Thompson RL, Wilkowske CJ. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA 1981; 245: 360-3.
27. Shah M. Teicoplanin in der Therapie der bakteriellen Endokarditis. Chemother J 1996; Suppl 11: 28-32.
28. Fortún J, Pérez-Molina JA, Anón MT, Martinez-Beltran J, Loza H, Guerrero A. Right-sided endocarditis caused by Staphylococcus aureus in drug abusers. Antimicrob Agents Chemother 1995; 39: 525-8.
29. Wilson APR, Grüneberg RN. Use of teicoplanin in community medicine. Eur J Clin Microbiol Infect Dis 1994; 13: 701-10.
30. Gilbert DN, Wood CA, Kimbrough RC, The Infectious Diseases Consortium of Oregon. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Siaphylococcus aureus intravascular infection. Antimicrob Agents Chemother 1991; 35: 79-87
31. Dinubile MJ. Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: the time has come? Eur J Clin Microbiol Infect Dis 1994; 13: 533-4.